Sense21 | HB-086 and HB-097 for Treatment of Chronic Sensory Neuronal Disorders - Neuropathic Pain and Hearing Loss
01-06-2022
-31-05-2026
Show more information
Organisation
HOBA THERAPEUTICS APS